Glucagon-like peptide-1 (GLP-1) analogs have been an important inclusion to the diabetes treatment portfolio with rapid marked access through diverse regions of the world in a similar way to iSGLT2 and metformin. The gene discussed is GCG; the disease is diabetes mellitus.